Invention Grant
US08975072B2 Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells 有权
包含可操作地连接到诱导型启动子的HPV E6 / E7的人类红系祖细胞系和用于产生人取出的红细胞的方法

  • Patent Title: Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells
  • Patent Title (中): 包含可操作地连接到诱导型启动子的HPV E6 / E7的人类红系祖细胞系和用于产生人取出的红细胞的方法
  • Application No.: US13745178
    Application Date: 2013-01-18
  • Publication No.: US08975072B2
    Publication Date: 2015-03-10
  • Inventor: Yukio NakamuraRyo Kurita
  • Applicant: Riken
  • Applicant Address: JP Saitama
  • Assignee: Riken
  • Current Assignee: Riken
  • Current Assignee Address: JP Saitama
  • Agency: Sughrue Mion, PLLC
  • Priority: JP2012-161878 20120720
  • Main IPC: C12N5/02
  • IPC: C12N5/02 C12N5/07 C12N15/85 C12N15/86 C12N5/078
Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells
Abstract:
Provided are: a method for producing an immortalized human erythroid progenitor cell line, enabling efficient and stable production of enucleated red blood cells; and a method for producing human enucleated red blood cells from a human erythroid progenitor cell line obtained by the aforementioned production method. An expression cassette capable of inducing expression of HPV-E6/E7 genes in the presence of DOX was introduced into the genomic DNA of blood stem cells. Then, the blood stem cells were cultured in the presence of DOX and a blood growth factor. Thereby, immortalized cell lines of human erythroid progenitor cells were established. Further, it was revealed that culturing the cell lines under a condition where the expression of the HPV-E6/E7 genes was not induced enabled differentiation induction into enucleated red blood cells at a high ratio.
Information query
Patent Agency Ranking
0/0